The recent understanding is that EBR, a member of the BRs, induces apoptosis more effectively in nuclear hormone receptor (NHR)-expressing cancer cell lines, such as LNCaP prostate [with androgen receptor (AR)] [4] or MCF-7 breast cancer cell lines [with estrogen receptor (ER)] [3]. Here, AR is linked to breast carcinoma.